2011
DOI: 10.4061/2011/808607
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Respiratory Muscle Endurance Training in Patients with Myasthenia Gravis: First Results after Four Months of Training

Abstract: Myasthenia gravis (MG) is characterized by reduced muscle endurance and is often accompanied by respiratory complications. Improvement of respiratory function is therefore an important objective in MG therapy. A previous study demonstrated that respiratory muscle endurance training (RMET) over four weeks increased respiratory muscle endurance of MG patients to about 200% of baseline. The purpose of the present study was to establish an appropriate maintenance training and to test its effects over four months. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
17
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 32 publications
2
17
0
Order By: Relevance
“…Respiratory muscle endurance (RME) has been evaluated over the years in a wide range of patient populations such as spinal cord injury (Silva, Neder & Chiurciu, 2000) chronic obstructive pulmonary disease (COPD) (Dias et al,2013;Weiner et al,2003), myasthenia gravis (Rassler et al, 2011), as well as in healthy individuals (Johnson, Cowley, Kinnear, 1997;Spengler, Roos, Laube et al, 1999;Johnson, Sharpe & Brown, 2007;Bell et al, 2013). This evaluation has been used as an outcome measurement following different treatment interventions and to determine normative values for respiratory muscle performance (Fiz, Romero, Gomez et al, 1998;Verges, Boutellier, & Spengler, 2008;Kroff & Terblanche, 2010;Fischer, Tarperi, George et al,2014.…”
Section: Introductionmentioning
confidence: 99%
“…Respiratory muscle endurance (RME) has been evaluated over the years in a wide range of patient populations such as spinal cord injury (Silva, Neder & Chiurciu, 2000) chronic obstructive pulmonary disease (COPD) (Dias et al,2013;Weiner et al,2003), myasthenia gravis (Rassler et al, 2011), as well as in healthy individuals (Johnson, Cowley, Kinnear, 1997;Spengler, Roos, Laube et al, 1999;Johnson, Sharpe & Brown, 2007;Bell et al, 2013). This evaluation has been used as an outcome measurement following different treatment interventions and to determine normative values for respiratory muscle performance (Fiz, Romero, Gomez et al, 1998;Verges, Boutellier, & Spengler, 2008;Kroff & Terblanche, 2010;Fischer, Tarperi, George et al,2014.…”
Section: Introductionmentioning
confidence: 99%
“…For a statistical power of 80% and the significance level of 5%, a sample size of 18 participants was calculated to determine a 15% change in myasthenia score improvement [5]. To avoid the influence of age, sex, and body mass index on the pulmonary function [10,11], sixteen age-, sex-, and BMI-matched MG patients who were not willing to undergo RMT were included as disease controls.…”
Section: Methodsmentioning
confidence: 99%
“…Class V is defined by the need for intubation, with or without mechanical ventilation, except when used during routine postoperative management. The effect of RMT may be performed safely and effectively in mild to moderate MG patients (classes II and III) with impairment of respiratory function [5,6].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The heterogeneity of of daily living, which further contributes to muscle weakness. 7,18 Pulmonary function in neurodegenerative disorders of the CNS is generally characterized by reduced inspiratory and expiratory pressure and a restrictive spirometric pattern. 1,16,19 At early stages of disease, there are only slight abnormalities in pulmonary function; however, at later stages, when there is considerable muscle weakness, vital capacity and FVC are reduced dramatically.…”
Section: Data Synthesis and Analysismentioning
confidence: 99%